FRUITS-ECO-BLOCKCHAIN
4.11.2022 15:01:43 CET | Business Wire | Press release
Fruits Eco-Blockchain Project (hereinafter, Fruits), a blockchain project striving towards financial inclusion and a sustainable ecosystem, has released a message of support from boxing legend and eight-division boxing world champion Manny Pacquiao and a roadmap for future activities.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221101006428/en/
Manny Pacquiao supports Fruits (Graphic: Business Wire)
Mr. Pacquiao has expressed his support upon collaboration with Fruits.
We will be working with Mr. Pacquiao to create a world where one’s consumption leads to another’s enhancement by using the sustainable ecosystem as envisioned by Fruits.
Please click the following URL to watch the video.
(Video URL)
https://youtu.be/l_Y6xuJjLWk
Roadmap
- Started deliberations with Mr. Pacquiao for launching a charity project in the Philippines. Discussions will continue until November 2022
- Commence the sale of subscription-based NFT for supporting charities by the end of 2022
- Launch of Fruits’ first blockchain game that promotes contributions to charity at the beginning of 2023
- Renewal of Fruits Station and organization of a periodic charity event using crowdfunding scheduled to launch in the end of Q1 2023
- Launch projects and organize charity events in collaboration with international sports legends in boxing, soccer, and other fields from March 2023 onwards
Details will be posted on the official homepage in due course.
[Support for the Fruits Station Donation Project]
Fruits is involved in charity initiatives through Fruits Station (https://fruits-station.com) to help the famine-stricken and impoverished citizens of the world.
We are undergoing a large-scale renewal and a crowdfunding-based charity platform is scheduled to launch in the end of Q1 2023.
Through this project, we want to build a sustainable ecosystem in collaboration with global influential individuals including Mr. Pacquiao and other legendary athletes.
Please see the roadmap of our charity activities to be conducted with the support of Mr. Pacquiao.
We are building a sustainable ecosystem to ensure children and families struggling with various issues become self-sufficient and have access to financial services.
What is Fruits
-
Fruits Official Website
https://fruitsblockchain.com/ -
Fruits Official Telegram (English)
https://t.me/fruits_official -
Fruits Official Linktree
https://linktr.ee/fruitsecoblockchain -
Fruits Official Medium (English)
https://medium.com/@fruitsblockchain -
FRUITS Station
https://fruits-station.com
“Fruits Wallet” Application Download
-
App Store
https://apps.apple.com/jp/app/fruits-wallet/id1585148044 -
Google Play
https://play.google.com/store/apps/details?id=com.fruits.wallet&hl=ja&gl=US
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221101006428/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
U.S. Food and Drug Administration Accepts New Drug Application and Grants Priority Review for Takeda’s Oveporexton (TAK-861) as a Potential First-in-Class Therapy for Narcolepsy Type 110.2.2026 09:15:00 CET | Press release
This FDA Acceptance is a Milestone for People Living with Narcolepsy Type 1 Who Need New and Different Treatment OptionsOveporexton is an Orexin Agonist Designed to Restore Orexin Signaling and Address the Underlying Orexin Deficiency that Causes Narcolepsy Type 1The Prescription Drug User Fee Act (PDUFA) Target Action Date is the Third Quarter of this Calendar Year Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) accepted its New Drug Application (NDA) and granted Priority Review for oveporexton (TAK-861) for the treatment of narcolepsy type 1 (NT1). Oveporexton is an investigational oral orexin receptor 2 (OX2R)-selective agonist designed to address the underlying orexin deficiency that causes NT1 by restoring orexin signaling. The FDA has set a Prescription Drug User Fee Act (PDUFA) goal date in the third quarter of this calendar year. Takeda remains on track to potentially bring the first approved orexin agonist treatment to people living
Swiss Leader Leonteq Chooses ActiveViam to Deliver High‑Performance FRTB Risk Analytics10.2.2026 09:00:00 CET | Press release
ActiveViam, a global leader in real‑time, multidimensional risk analytics for capital markets, today announced that Leonteq, one of the leading Swiss providers of structured products, has implemented Atoti to calculate Market Risk Capital Charges under the Standardized Approach of the Fundamental Review of the Trading Book (SA-FRTB). ActiveViam’s flagship product, Atoti, is being used by Leonteq as its FRTB reporting solution to the Swiss Financial Market Supervisory Authority (FINMA). Switzerland implemented FRTB for its banks on 1st January 2025 and FINMA recently extended its scope to include Leonteq. When the FRTB implementation deadlines became clear, Leonteq evaluated several vendors for a solution that could integrate with its existing pricing engines. After a detailed assessment, it selected Atoti. The solution provides dashboards and preconfigured reports that meet FINMA’s requirements, along with analytics aligned to the ISDA Unit Tests and additional capabilities such as wha
Bending Spoons offers €1.5 million in tech scholarships through new Fellowship program10.2.2026 09:00:00 CET | Press release
Today Bending Spoons announced the launch of the Bending Spoons Fellowship, committing up to €1.5 million to support Europe’s most outstanding computer science students through the program. The fellowship will award ten scholarships—each worth €50,000 per year and renewable for up to three years—to high-achieving university students in computer science and related fields across Europe and the UK. “We think exceptional talent deserves exceptional opportunities,” said Costanza Mazzei, the Bending Spoons talent manager leading the program. “With the Bending Spoons Fellowship, we aim to give Europe’s most driven students the freedom, resources, and guidance to reach the highest levels of excellence.” In addition to financial support, Fellowship participants will benefit from individual mentorship and may choose to participate in an optional paid summer internship at Bending Spoons. The fellowship is the latest initiative from Bending Spoons to support emerging technical talent. It builds o
Ralph Haupter Joins Warburg Pincus as an External Senior Advisor10.2.2026 09:00:00 CET | Press release
Seasoned Technology Executive to Support European Technology Group Warburg Pincus, the pioneer of private equity global growth investing, today announced that Ralph Haupter will serve as an External Senior Advisor to its European Technology team. Mr. Haupter, Executive Vice President and Chief Revenue Officer for Small Medium Enterprises and Channel (SME&C) at Microsoft, will take on this personal engagement to help the firm identify and evaluate new investment opportunities across the software and technology sectors. He will also play an active role in value creation across the firm’s existing portfolio. Mr. Haupter brings over 25 years of global operating experience and deep expertise in technology innovation and transformation. At Microsoft, he leads a global organization that works with the company’s extensive partner ecosystem to empower small and medium businesses worldwide. Previously, he held senior leadership roles across Europe, Asia, and the Americas, including President of
CapVest Enters Exclusive Discussions With HLD on the Proposed Acquisition of TSG10.2.2026 09:00:00 CET | Press release
HLD and management to retain significant minority stakes in TSG, partnering with CapVest on a shared vision to lead the company into its next phase of global growth CapVest Partners LLP (“CapVest”), a leading New York and London based investment firm, and HLD, the entrepreneurial European investment group, have entered exclusive discussions on CapVest’s proposed acquisition of a majority stake in TSG, a European leader in technical services for critical energy infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260210375858/en/ Headquartered in Paris, France, TSG is a European leader in technical services for the energy industry with a pan-European footprint in over 30 countries and employing over 7,000 people. Originally focused on fuel station and private fleet energy infrastructure and systems, since HLD’s acquisition of the company in 2020 TSG has undergone significant transformation as a primary enabler of th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
